Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.
SVP, Head of Regulatory Affairs and PV Operations
Astellas
SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb
In this engaging panel discussion, global leaders in pharmaceutical IT and pharmacovigilance share their expertise on how to get the most value out of technology investments, achieving significant efficiency and cost savings.
Transform literature monitoring with our system-agnostic, GenAI-powered solution.
Enable smarter, faster literature management with cutting-edge GenAI capabilities.
Leading organizations are embracing the latest innovations in Safety, including advanced automation and GenAI technologies, to drive unprecedented value.
AI & Automation: How does your company’s progress rank compared to the findings of our new industry survey?
Here’s what you should focus on to ensure you get the most out of your Safety platform.
In the ever-evolving pharmacovigilance landscape , embracing automation and AI has become a strategic necessity for global pharmaceutical companies.
Our expert speakers share real-world experiences, providing actionable insights to empower your organization in adopting best practices for PV safety automation.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
